Mycoplasma Testing Market

Mycoplasma Testing Market by Product & Services (Kits & Reagent and Instruments), Technique (PCR, ELSA, Enzymatic Methods, and DNA Staining), Application (Cell Line Testing and Virus Testing), End User (Pharmaceutical Companies and Cell Banks) - Global Forecast to 2022

Report Code: BT 3371 Jun, 2017, by marketsandmarkets.com

[156 Pages Report] Mycoplasma is a common source of contamination in biopharmaceutical production, cultivation of stem cells, and tissue engineering. Pharmaceutical and biotechnology companies carry out mycoplasma testing to investigate altered growth rates, morphological changes, chromosomal aberrations, and metabolism alterations. Mycoplasma testing is used for bulk and final drug products, cell banks, and raw materials. The global mycoplasma testing market is expected to reach USD 943.4 Million by 2022 from USD 523.3 Million in 2017, at a CAGR of 12.5% during forecast period. Increasing growth and government support of pharmaceutical and biotechnology industries, strong trend of R&D investments in life science, and rising cell culture contamination will drive the growth of the mycoplasma testing market. In the coming years, emerging markets and increasing pharmaceutical outsourcing are expected to offer growth opportunities for players in the mycoplasma testing market.

Mycoplasma Testing Market

By product, kits & reagents segment is expected to grow at the highest growth rate during the forecast period

The kits & reagents segment is projected to register the highest during the forecast period. The frequent purchase of these consumables as compared to instruments and increasing use of kit-based techniques for mycoplasma testing are the important factors driving the growth of this segment.

Mycoplasma Testing Market

By technique, PCR segment to record the highest CAGR during the forecast period

PCR segment is projected to register a higher CAGR during the forecast period. Highest CAGR of this segment can be attributed to the high acceptance rate of PCR due to the accuracy, speed, and flexibility provided by this technique in life sciences research. Moreover, this technique offers high sensitivity and a lower turnaround time. PCR is widely used for the detection of mycoplasma in research and biopharmaceutical production. It has been considered an efficient method for the detection of mycoplasma as it is relatively fast, inexpensive, and is not affected by cell culture conditions.

By application type, cell line testing segment to record the highest CAGR during the forecast period

Cell line testing application segment is projected to register a higher CAGR during the forecast period. Factors such as a rapid growth of the biopharmaceutical industry and increasing demand for monoclonal antibodies are driving the growth of this segment.

By end user type, pharmaceutical & biotechnology companies segment to record the highest CAGR during the forecast period

Pharmaceutical & biotechnology companies’ end user segment is projected to register a higher CAGR during the forecast period. Pharmaceutical and biotechnology companies primarily carry out large-scale, preparative cell cultures. Significant growth in R&D investments in the pharmaceutical industry is the primary growth driver of this end-user segment. The increase in the number of biotechnology and pharmaceutical patents granted worldwide is also expected to impact the growth of this market.

North America to account for the largest market size during the forecast period.

North America is expected to account for the largest share of this market. The large share of North America is attributed to the high adoption rate of novel technologies and the large number of life science research studies conducted in this region.

Mycoplasma Testing Market

Market Dynamics

Driver: Increasing growth and government support for pharmaceutical and biotechnology industries

Pharmaceutical and biotechnology companies are the largest end users in the mycoplasma testing market. Mycoplasma testing is carried out in the research and production of all biopharmaceutical products. Growth in the pharmaceutical and biotechnology sector across the globe serves as a direct driver for associated markets such as mycoplasma testing.

The pharmaceutical and biotechnology market across several geographies is growing at a significant rate. According to the International Trade Administration, the global pharmaceuticals market is projected to grow from USD 1 trillion in 2015 to USD 1.3 trillion by 2020, at a CAGR of 4.9%. The Indian pharmaceuticals market, as reported by the India Brand Equity Foundation, is expected to reach USD 55 billion by 2020 from USD 36.7 billion in 2016, at a CAGR of 15.92%. The Indian biotechnology sector was valued at an estimated USD 4 billion in 2011; it was projected to reach USD 10 billion by 2015. Strong growth in the pharmaceutical and biopharmaceutical industries will drive the mycoplasma testing market.

Opportunity: Increasing pharmaceutical outsourcing

The R&D expenditure in the pharmaceutical industry is very high. According to PhRMA, its member companies invested an estimated USD 58.8 billion in research and development (R&D) in 2015, an increase of 10.3% from 2014. Contract research organizations act as outsourcing partners for pharmaceutical and biotechnology companies and academic institutes. Many pharmaceutical and biotechnology companies and academic institutes opt to outsource functions like manufacturing, clinical trial management, and drug discovery to CROs. Pharmaceutical research outsourcing enables these organizations to decrease their operational costs. Furthermore, owing to technological advancements and the emergence of new technologies, it is not feasible for companies to undertake all testing functions in-house. CROs can afford to invest in an extensive drug discovery infrastructure as they cater to multiple clients. This makes investing in advanced techniques like PCR, ELISA, and cell line authentication and characterization tests a cost-effective option for CROs. With the help of CROs, pharmaceutical and biotechnology companies can reduce their operational costs and R&D budgets. With the growth in outsourcing R&D activities, the demand for mycoplasma testing services from CROs is estimated to increase. The rise in outsourcing thus provides significant growth opportunities for the market.

Challenge: Dearth of skilled professionals

The success of mycoplasma tests depends mainly on the expertise of the analysts themselves as much as the environmental conditions under which the test is performed. For optimal efficacy, mycoplasma testing needs to be conducted by skilled professionals with sufficient knowledge of the nuances of this field. Handling the instruments used in mycoplasma testing also requires expertise. Consequently, the dearth of a sufficiently skilled workforce poses a key challenge to the growth of the mycoplasma testing market.

Scope of the Report

Report Metric

Details

Market size available for years

2016–2022

Base year considered

2016

Forecast period

2017–2022

Forecast units

Million (USD)

Segments covered

Product and Services

  • Kits & Reagents
    • PCR Assays
    • Nucleic Acid Detection Kits
    • Elimination Kits & Reagents
    • Stains
    • Standards & Controls
    • Other Kits & Reagents
  • Services
  • Instruments

By Technique

  • PCR
  • ELISA
  • Direct Assays
  • Indirect Assays
  • DNA Staining
  • Microbial Culture Techniques
  • Enzymatic Methods

By Application

  • Cell Line Testing
  • Virus Testing
  • End-of Production Cell testing
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks
  • Other End Users

Geographies covered

North America, Europe, Asia, RoW

Companies covered

     11.1 Charles River Laboratories International, Inc
     11.2 Merck KGaA
     11.3 Lonza Group Ltd.
     11.4 ROCHE DIAGNOSTICS (DIVISION OF F. HOFFMAN-LA ROCHE LTD.)
     11.5 SGS S.A.
     11.6 Thermo Fisher Scientific Inc.
     11.7 American Type Culture Collection
     11.8 Biounique Testing Laboratories Inc.
     11.9 Invivogen
     11.10 Promocell GMBH
     11.11 Biological Industries Israel Beit Haemek Ltd.
     11.12 Wuxi APPTEC
     11.13 Norgen Biotek Corporation

The research report categorizes the mycoplasma testing market into the following segments and subsegments:

By Product

  • Kits & Reagents
    • PCR Assays
    • Nucleic Acid Detection Kits
    • Elimination Kits & Reagents
    • Stains
    • Standards & Controls
    • Other Kits & Reagents
  • Services
  • Instruments

By Technique

  • PCR
  • ELISA
  • Direct Assays
  • Indirect Assays
  • DNA Staining
  • Microbial Culture Techniques
  • Enzymatic Methods

By Application

  • Cell Line Testing
  • Virus Testing
  • End-of Production Cell testing
  • Other Applications

By End User

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Cell Banks
  • Other End Users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia
  • RoW

Key Market Players

Thermo Fisher Scientific, Inc., Roche Diagnostics, Merck KGaA, Lonza Group Ltd, Charles River Laboratories International, Inc., InvivoGen, PromoCell GmbH, Bionique Testing Laboratories, Inc., and American Type Culture Collection.

Mycoplasma Testing Market

Critical questions the report answers:

  • Where will all these developments take the industry in the long term?
  • What are the upcoming trends for the mycoplasma testing market?
  • Which segment provides the most opportunity for growth?
  • Who are the leading vendors operating in this market?
  • What are the opportunities for new market entrants?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Market Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 18)
    2.1 Secondary Data
           2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
           2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown & Data Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 31)
    4.1 Mycoplasma Testing: Market Overview
    4.2 Geographic Analysis: Mycoplasma Testing Market, By Application (2017)
    4.3 Mycoplasma Testing Market, By Product and Service, 2017–2022
    4.4 Geographical Snapshot of the Mycoplasma Testing Market

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Growth and Government Support for Pharmaceutical and Biotechnology Industries
                    5.2.1.2 Strong Trend of R&D Investments in Life Sciences
                    5.2.1.3 Cell Culture Contamination—A Major Concern for Laboratories
           5.2.2 Restraints
                    5.2.2.1 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
                    5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Pharmaceutical and Biotechnology Companies
           5.2.3 Opportunity
                    5.2.3.1 Increasing Pharmaceutical Outsourcing
           5.2.4 Challenge
                    5.2.4.1 Shortage of Skilled Professionals

6 Mycoplasma Testing Market, By Product & Service (Page No. - 39)
    6.1 Introduction
    6.2 Kits & Reagents
           6.2.1 PCR Assays
           6.2.2 Nucleic Acid Detection Kits
           6.2.3 Elimination Kits & Reagents
           6.2.4 Stains
           6.2.5 Standards & Controls
           6.2.6 Other Kits & Reagents
    6.3 Instruments
    6.4 Services

7 Mycoplasma Testing Market, By Technique (Page No. - 48)
    7.1 Introduction
    7.2 PCR
    7.3 Elisa
    7.4 Direct Assays
    7.5 Indirect Assays
    7.6 Dna Staining
    7.7 Microbial Culture Techniques
    7.8 Enzymatic Methods

8 Mycoplasma Testing Market, By Application (Page No. - 54)
    8.1 Introduction
    8.2 Cell Line Testing
    8.3 Virus Testing
    8.4 End-Of-Production Cell Testing
    8.5 Other Applications

9 Mycoplasma Testing Market, By End User (Page No. - 60)
    9.1 Introduction
    9.2 Pharmaceutical and Biotechnology Companies
    9.3 Contract Research Organizations
    9.4 Academic Research Institutes
    9.5 Cell Banks
    9.6 Other End Users

10 Geographic Analysis (Page No. - 67)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 U.K.
             10.3.3 France
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 Rest of Europe (RoE)
     10.4 Asia
             10.4.1 China
             10.4.2 Japan
             10.4.3 India
             10.4.4 Rest of Asia (RoA)
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 104)
     11.1 Introduction
     11.2 Vendor Dive Overview
             11.2.1 Vanguards
             11.2.2 Innovators
             11.2.3 Dynamic
             11.2.4 Emerging
     11.3 Competitive Benchmarking
             11.3.1 Analysis of Product Portfolio of Major Players in Mycoplasma Teting Market (25 Players)
             11.3.2 Business Strategies Adopted By Major Players in the Mycoplasma Testing Market(25 Players)

*Top 25 Companies Analyzed for This Studies are - Charles River Laboratories International, Inc.(U.S.), Merck KGaA (Germany),Roche Diagnostics ( Switzerland), Lonza Group Ltd. (Switzerland), SGS S.A. (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.),Invivogen (U.S.), Promo Cell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd, Wuxi Apptec.(U.S.), Norgen Biotek Corp.(Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A.(Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories(U.S.), Genecopoeia Inc.(U.S.), Genbio(Canada), Hylabs(Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Sartorius AG (Germany), Savyon Diagnostics(Israel), Sciencell Research Laboratories, Inc.(Canada)

12 Company Profiles (Page No. - 108)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Charles River Laboratories International, Inc.
             12.1.1 Overview
             12.1.2 Product/Services Offered
             12.1.3 Product Offering Scorecard
             12.1.4 Business Strategy Scorecard
             12.1.5 Recent Developments (2014 – March 2017)
     12.2 Merck Kgaa
             12.2.1 Overview
             12.2.2 Product/Services Offered
             12.2.3 Product Offering Scorecard
             12.2.4 Business Strategy Scorecard
             12.2.5 Recent Developments (2014 – March 2017)
     12.3 Lonza Group Ltd.
             12.3.1 Overview
             12.3.2 Product/Services Offered
             12.3.3 Product Offering Scorecard
             12.3.4 Business Strategy Scorecard
             12.3.5 Recent Developments (2014 – March 2017)
     12.4 Roche Diagnostics (Division Of F. Hoffman-La Roche Ltd.)
             12.4.1 Overview
             12.4.2 Product/Services Offered
             12.4.3 Product Offering Scorecard
             12.4.4 Business Strategy Scorecard
             12.4.5 Recent Developments (2014 – March 2017)
     12.5 SGS S.A.
             12.5.1 Overview
             12.5.2 Product/Services Offered
             12.5.3 Product Offering Scorecard
             12.5.4 Business Strategy Scorecard
             12.5.5 Recent Developments (2014 – March 2017)
     12.6 Thermo Fisher Scientific Inc.
     12.7 American Type Culture Collection
     12.8 Biounique Testing Laboratories Inc.
     12.9 Invivogen
     12.10 Promocell GmbH
     12.11 Biological Industries Israel Beit Haemek Ltd.
     12.12 Wuxi Apptec
     12.13 Norgen Biotek Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 146)
     13.1 Industry Insights
     13.2 Discussion Guide
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports
     13.7 Author Details


List of Tables (73 Tables)

Table 1 Mycoplasma Testing: Market Snapshot
Table 2 Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 3 Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022(USD Million)
Table 4 Mycoplasma Testing Kits & Reagents Market Size, By Region, 2015–2022 (USD Million)
Table 5 PCR Assays Market Size, By Region, 2015–2022 (USD Million)
Table 6 Nucleic Acid Detection Kits Market Size, By Region, 2015–2022 (USD Million)
Table 7 Elimination Kits & Reagents Market Size, By Region, 2015–2022 (USD Million)
Table 8 Mycoplasma Testing Stains Market Size, By Region, 2015–2022 (USD Million)
Table 9 Standards & Controls Market Size, By Region, 2015–2022 (USD Million)
Table 10 Other Kits & Reagents Market Size, By Region, 2015–2022 (USD Million)
Table 11 Mycoplasma Testing Instruments Market Size, By Region, 2015–2022 (USD Million)
Table 12 Mycoplasma Testing Services Market Size, By Region, 2015–2022 (USD Million)
Table 13 Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 14 Mycoplasma Testing Market Size for PCR, By Region, 2015–2022 (USD Million)
Table 15 Elisa Method Market Size, By Region, 2015–2022 (USD Million)
Table 16 Direct Assays Market Size, By Region, 2015–2022 (USD Million)
Table 17 Indirect Assays Market Size, By Region, 2015–2022 (USD Million)
Table 18 Dna Staining Market Size, By Region, 2015–2022 (USD Million)
Table 19 Microbial Culture Techniques Market Size, By Region, 2015- 2022 (USD Million)
Table 20 Enzymatic Methods Market Size, By Region, 2015–2022 (USD Million)
Table 21 Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 22 Mycoplasma Testing Market Size for Cell Line Testing, By Region, 2015–2022 (USD Million)
Table 23 Mycoplasma Testing Market Size for Virus Testing, By Region, 2015–2022 (USD Million)
Table 24 Mycoplasma Testing Market Size for End-Of-Production Cell Testing, By Region, 2015–2022 (USD Million)
Table 25 Other Mycoplasma Testing Applications Market Size, By Region, 2015–2022 (USD Million)
Table 26 Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 27 Mycoplasma Testing Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2015–2022 (USD Million)
Table 28 Mycoplasma Testing Market Size for Contract Research Organizations, By Region, 2015–2022 (USD Million)
Table 29 Mycoplasma Testing Market Size for Academic Research Institutes, By Region, 2015–2022 (USD Million)
Table 30 Mycoplasma Testing Market Size for Cell Banks, By Region, 2015–2022 (USD Million)
Table 31 Mycoplasma Testing Market Size for Other End Users, By Region, 2015–2022 (USD Million)
Table 32 Mycoplasma Testing Market Size, By Region, 2015–2022 (USD Million)
Table 33 North America: Mycoplasma Testing Market Size, By Country, 2015–2022 (USD Million)
Table 34 North America: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 35 North America: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 36 North America: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 37 North America: Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 38 North America: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 39 U.S.: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 40 U.S.: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 41 U.S.: Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 42 U.S.: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 43 Canada: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 44 Canada: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 45 Canada: Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 46 Canada: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 47 Europe: Mycoplasma Testing Market Size, By Country, 2015–2022 (USD Million)
Table 48 Europe: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 49 Europe: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 50 Europe: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 51 Europe: Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 52 Europe: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 53 Germany: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 54 U.K.: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 55 France: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 56 Italy: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 57 Spain: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 58 RoE: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 59 Asia: Mycoplasma Testing Market Size, By Country, 2015–2022 (USD Million)
Table 60 Asia: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 61 Asia: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 62 Asia: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 63 Asia: Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 64 Asia: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)
Table 65 China: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 66 Japan: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 67 India: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 68 RoA: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 69 RoW: Mycoplasma Testing Market Size, By Product & Service, 2015–2022 (USD Million)
Table 70 RoW: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015–2022 (USD Million)
Table 71 RoW: Mycoplasma Testing Market Size, By Technique, 2015–2022 (USD Million)
Table 72 RoW: Mycoplasma Testing Market Size, By Application, 2015–2022 (USD Million)
Table 73 RoW: Mycoplasma Testing Market Size, By End User, 2015–2022 (USD Million)


List of Figures (36 Figures)

Figure 1 Global Mycoplasma Testing Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Mycoplasma Testing Market: Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Mycoplasma Testing Market Size, By Product and Service, 2017 vs 2022 (USD Million)
Figure 8 Mycoplasma Testing Kits and Reagents Market Size, By Type, 2017 vs 2022 (USD Million)
Figure 9 Mycoplasma Testing Market Size, By Technique, 2017 vs 2022 (USD Million)
Figure 10 Mycoplasma Testing Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 11 Mycoplasma Testing Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 12 Mycoplasma Testing Market Size, By Region, 2017 vs 2022 (USD Million)
Figure 13 Growing Pharmaceutical and Biotechnological Industries—Major Factor Driving Market Growth
Figure 14 Cell Line Testing Segment to Command the Largest Market Share in 2017
Figure 15 Services Segment to Register the Highest CAGR During the Forecast Period
Figure 16 Asia to Register the Highest CAGR Between 2017 & 2022
Figure 17 Mycoplasma Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Kits & Reagents is Expected to Command the Largest Share of the Mycoplasma Testing Market in 2017
Figure 19 Global Mycoplasma Testing Market, By Technique
Figure 20 Cell Line Testing Will Be the Fastest-Growing Application Segment Durng Forecast Period
Figure 21 Pharmaceutical & Biotechnology Companies Segment to Dominate the Mycoplasma Testing Market in 2017
Figure 22 Asia to Register the Highest CAGR During the Forecast Period
Figure 23 U.S. to Dominate the North American Mycoplasma Testing Market in 2022
Figure 24 North America: Mycoplasma Testing Market Snapshot
Figure 25 Europe: Mycoplasma Testing Market Snapshot
Figure 26 Germany to Register the Highest CAGR in the European Mycoplasma Testing Market During the Forecast Period
Figure 27 China Will Continue to Dominate the Asian Mycoplasma Testing Market in 2022
Figure 28 Asia: Mycoplasma Testing Market Snapshot
Figure 29 RoW: Mycoplasma Testing Market Snapshot
Figure 30 Dive Chart
Figure 31 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 32 Merck KGaA: Company Snapshot (2016)
Figure 33 Lonza Group Ltd.: Company Snapshot (2016)
Figure 34 F. Hoffmann-LA Roche Ltd.: Company Snapshot (2016)
Figure 35 SGS S.A.: Company Snapshot (2016)
Figure 36 Thermo Fisher Scientific Inc.: Company Snapshot (2016)


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
BT 3371
Published ON
Jun, 2017
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Mycoplasma Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

Home